Showing 921-930 of 10620 results for "".
The Skin Cancer Foundation at 40
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-skin-cancer-foundation-at-40/19614/Skin Cancer Foundation president Deborah Sarnoff, MD talks about the Foundation's accomplishments, its current focus, and future goals. Founded in 1979, the foundation has helped educate the public on skin cancer risk and supports dermatologists in practice.Skin of Color Society in NYC; Highlights from 2017
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-skin-of-color-society-in-nyc-highlights-from-2017/18359/In this special edition of DermWireTV, Seemal Desai, MD offers a recap of the Skin of Color Society's media day in New York. Plus, a look at the most-read and viewed content from Practical Dermatology® magazine and DermTube.com, featuring Heidi Waldorf, MD, Linda Stein-Gold, MD, Ted Rosen, MD, JoelSunscreen Ratings, Long Live Skin Launches, SCALE Highlights
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-sunscreen-ratings-long-live-skin-launches-scale-highlights/18471/Consumer Reports says that one-third of sunscreens tested in its latest evaluation provided less than half of the SPF protection touted on the label. For its part, the American Academy of Dermatology is reminding patients that sunscreen ingredients are safe. The Environmental Working Group continuesBehind the Scenes: Preparing to Inject
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aad-orlando-daily-coverage-day---wvpotpwa/18529/Live injection sessions are a great way to learn techniques and review injection anatomy for best outcomes and patient safety. Doris Day, MD speaks about these issues and shares her perspective on preparing to inject for these sessions.Biosimilar Recommended; Saunders to Head New Pfizer/Allergan Organization
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-biosimilar-recommended-saunders-to-head-new-pfizer-allergan-organization/18825/An FDA committee has recommended Pfizer's Inflectra, biosimilar to infliximab, developed by Celltrion. Sunbelt Melanoma Trial finds no benefit for IFN in Phase III melanoma. Pfizer/Allergan provides details on structure of new organization and announces leadership, including President and COO BrentSystemic Implications of Psoriasis
https://practicaldermatology.com/topics/psoriasis/systemic-implications-of-psoriasis/18636/Although a disease with a presentation on the skin, psoriasis has important implications for systemic health. Joel Gelfand, MD, talks about the increased risk for diabetes and cardiovascular disease in patients with psoriasis, as well as the clinician's role in educating patients about their diseaseSpecial Considerations in Psoriasis Treatment
https://practicaldermatology.com/topics/psoriasis/special-considerations-in-psoriasis-treatment/18686/Steven R. Feldman, MD, PhD sits down with DermTube Journal Club host Joshua Zeichner, MD to talk about special treatment considerations for psoriasis. He offers tips for treating pregnant patients with psoriasis and the safety of certain topicals and biologics for this population. Dr. Feldman discus2014 Year in Review: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2014-year-in-review-skin-cancer/19001/Gary Goldenberg, MD offers a snapshot look at the newest therapies in the skin cancer treatment landscape, as well as the newest innovations across various disease states in the specialty.Ask an Expert: Sheila Fallon Friedlander, MD on the Molluscum Pipeline
https://practicaldermatology.com/topics/general-topics/ask-an-expert-sheila-fallon-friedlander-md-on-the-molluscum-pipeline/19006/Sheila Fallon Friedlander, MD talks to host Adam Friedman, MD about the pipeline of treatments for molluscum in pediatric patients. From NewDermMD.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.